Abortion advocates must tell the truth
World
By Ericka Andersen
A comprehensive study released today from EPPC shows that more than 10% of women who took the Mifepristone pill experienced sepsis, infection, hemorrhaging or other serious problems within 45 days of the doing so. EPPC combed close to 900,000 insurance claims for women prescribed mifepristone abortions from 2017-2023.
The FDA should view these findings and reconsider the safety of current, loose restrictions that put women in harm’s way.